Abstract
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have